Pfizer Tells 1st Circ. Neurontin MDL Shows No Proof Of Harm
Pfizer Inc. on Friday urged the First Circuit to uphold the dismissal of Blue Cross Blue Shield of Louisiana, several health plans and other third-party payors from multidistrict litigation over alleged...To view the full article, register now.
Already a subscriber? Click here to view full article